WHO 2024 hepatitis B guidelines: an opportunity to transform care

Lancet Gastroenterol Hepatol. 2024 Jun;9(6):493-495. doi: 10.1016/S2468-1253(24)00089-X. Epub 2024 Apr 10.

Authors

Philippa J Easterbrook¹, Niklas Luhmann², Sahar Bajis², Myat Sandi Min², Morkor Newman², Olufunmilayo Lesi², Meg C Doherty²

Affiliations

¹ Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, 20 Avenue Appia, Geneva, 1211 Switzerland. Electronic address: [email protected].
² Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, 20 Avenue Appia, Geneva, 1211 Switzerland.

PMID: 38614110
DOI: 10.1016/S2468-1253(24)00089-X

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Hepatitis B* / epidemiology
Hepatitis B* / prevention & control
Humans
Practice Guidelines as Topic*
World Health Organization*

Substances

Antiviral Agents

Grants and funding

001/WHO_/World Health Organization/International